top of page
Meningococcal Quadrivalent Vaccines
9 months to 55 years-old
Menactra
Provider:
SANOFI (賽諾菲)
Certification:
FDA & Hong Kong Department of Health
Suggested age:
9 months to 55 years-old
Disease Prevention:
Meningococcal quadrivalent vaccines protect against 4 types of meningococcal bacteria: types A, C, Y and W-135.
Side Effect:
Soreness, redness and swelling where the vaccine was given.
Interval:
9 - 23 months old: 2 dose, 3 months minimum interval
2-55 years old: 1 dose

Precautions:
/
bottom of page